BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced new data will be presented on the company’s sustained release technology at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting at the Colorado Convention Center in Denver, Colorado, from May 3-7, 2015. The data presented will focus on the
Uncategorized